# Regeneron Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 24, 2026

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: DEF 14A
- Filed: 2026-04-24
- Accepted by EDGAR: Apr 24, 2026, 16:02 ET
- Period: 2026-06-12
- Accession: 0001308179-26-000340
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm

Filed Apr 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001308179-26-000340. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.